Be Careful: These Biotechs Have Run Too Far Too Fast
Motley Fool experts offer insight into which biotech stocks they like, but might be getting too pricey.
Upcoming FDA Decisions We're Most Excited About
Three Motley Fool experts tell readers what upcoming FDA decisions have caught their eye.
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Tired of reading through mile-long earnings reports? Have a gander at the one sentence in each of these 10 big pharma earnings reports that tells you everything you need to know about these companies.
6 Reason Why You Should Reject the McDonald's Mini-Tender Offer
Acquiring shares at below-market prices is a tactic often used to snare unsuspecting investors